Join us to hear the powerful stories of four parents whose children and adults with autism participated in groundbreaking clinical trials of Microbiota Transplant Therapy (MTT), led by Prof. James Adams at Arizona State University.

Learn how MTT improved the lives of their children and adults with autism. Prof. James Adams will provide a concise overview of past, current, and future clinical trials. Successful entrepreneur Dan Feshbach (Teachtown, Multiple) will discuss with Dr. Adams how over 50 autism families are investing in Gut-Brain-Axis Therapeutics Inc. to support these clinical trials.

Organized by Multiple, an autism tech accelerator, innovation hub, and community network composed of autism investors and entrepreneurs.